Diligence memo · auto-generated · as of July 3, 2026
Oncoheroes Biosciences Inc.
Oncoheroes Biosciences Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Oncoheroes Biosciences Inc. operates in Biotech / Pharma, based in BROOKLINE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Oncoheroes Biosciences Inc. has raised $8.9M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $8.9M on 2018-02-26.
Most recent recorded round closed around 2018-02-26.
Valuation (modeled)modeled
Provath models Oncoheroes Biosciences Inc. at approximately $297M (range $9.9M–$1.6B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.36× the median modeled value of Series A Biotech / Pharma companies in 2016–2018 (5 peers) — value vs value, same stage and era. Within the normal band (136% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 8.3 yr ago; this sector typically re-raises about every 15 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 60% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 85% of those peers.
Closest niche peers: Pharmaca Integrative Pharmacy Inc, PharmacoPhotonics, Inc., Key Biologics Holdings, LLC, Swift Biosciences, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.